Funds and ETFs Baxter International Inc.

Equities

BAX

US0718131099

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:01 2024-06-07 EDT 5-day change 1st Jan Change
33.16 USD -0.48% Intraday chart for Baxter International Inc. -2.73% -14.23%

ETFs positioned on Baxter International Inc.

Name Weight AuM 1st Jan change Investor Rating
0.04% 9 M€ +9.52% -
0.04% 414 M€ +10.01% -
0.04% 1,166 M€ +0.26% -
0.04% 607 M€ +0.05% -
0.03% 205 M€ -.--%
0.03% 324 M€ +6.59% -
0.03% 40 M€ +6.57% -
0.03% 1 M€ +3.03% -
0.02% 322 M€ +13.88% -
0.02% 29 M€ -.--% -
0.02% 17 M€ +3.59% -
0.02% 18 M€ +3.81% -
0.02% 104 M€ +4.15% -
0.01% 6 M€ +3.89%
0.01% 32 M€ +4.30% -
0.01% 6 M€ -4.26% -
0.01% 8 M€ +1.08% -
0.01% 753 M€ +0.97% -
0.01% 55 M€ +1.07% -
0.01% 2 M€ +3.16% -
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
33.16 USD
Average target price
45.44 USD
Spread / Average Target
+37.03%
Consensus
  1. Stock Market
  2. Equities
  3. BAX Stock
  4. Funds and ETFs Baxter International Inc.